Начало・Списък с акции・Savara Inc

Savara Inc

Затворен

СекторЗдравеопазване

5.73 -1.72

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

5.82

Максимум

5.9

Ключови измерители
By Trading Economics
Приходи	-5M -37M
Служители	70
EBITDA	-3.8M -37M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+91.6% upside

Дивиденти
By Acuity
Следващи печалби	12.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	43M 1.1B
Предишно отваряне	7.45
Предишно затваряне	5.73

Savara Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

7.08.2026 г., 19:36 ч. UTC

Savara Inc is trading higher, benefiting from broader market gains following a weaker-than-expected jobs report that may delay Federal Reserve interest rate hikes.

6.08.2026 г., 20:06 ч. UTC

Savara Inc shares are higher today, recovering from earlier declines and trading above their 20-day moving average. No specific news was identified for the move.

5.08.2026 г., 19:36 ч. UTC

News

Savara Inc. shares are higher as the company advances its Biologics License Application for molgramostim, with a key PDUFA date approaching.

4.08.2026 г., 23:01 ч. UTC

Savara Inc shares are trading higher in after-market hours, showing significant volatility with no specific news identified to explain the price movement.

3.08.2026 г., 20:06 ч. UTC

Savara Inc is declining today, diverging from recent higher closes. Broader market indices, including the S&P 500 and Nasdaq 100, are gaining.

31.07.2026 г., 20:06 ч. UTC

Event

Savara Inc shares are lower despite the European Patent Office granting a patent for MOLBREEVI, effective through March 2041. The stock remains near its one-month low.

30.07.2026 г., 20:09 ч. UTC

Event

Savara Inc shares rise after the European Patent Office grants a patent for MOLBREEVI, providing protection until March 2041.

29.07.2026 г., 19:47 ч. UTC

Savara Inc's shares are lower, marking five consecutive sessions of decline. Broader market performance is mixed as traders await the Federal Reserve's interest rate decision.

28.07.2026 г., 19:16 ч. UTC

Savara Inc. shares are lower today amid ongoing price weakness. Broader markets like the FTSE 100 and DAX are showing resilience despite this decline.

27.07.2026 г., 14:02 ч. UTC

Savara Inc shares are higher during Monday's session, reaching their peak at 9:30 AM ET. No specific news was identified to explain the movement.

24.07.2026 г., 20:02 ч. UTC

Savara Inc shares are lower today, continuing a decline since Thursday amid high market volume. Broader market sentiment is affected by recent oil price volatility.

21.07.2026 г., 17:41 ч. UTC

Savara Inc. shares are advancing today amid strong trading volume. The broader market is also positive, led by gains in technology stocks.

20.07.2026 г., 20:06 ч. UTC

Savara Inc shares are higher, continuing their advance from Friday's close. Broader market sentiment remains mixed amid ongoing geopolitical concerns.

Сравнение с други в отрасъла

Ценова промяна

Savara Inc Прогноза

Ценова цел

By TipRanks

91.6% нагоре

12-месечна прогноза

Среден 11.17 USD 91.6%

Висок 16 USD

Нисък 9 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Savara Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Savara Inc през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.